Kingdon Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Kingdon Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60,461	Closed	-$2.2M	–	161
2016 Q4	$2.2M	Sell	60,461 -94,502	-61%	-$3.34M	0.11%	109
2016 Q3	$5.91M	Buy	+154,963	New	+$2.29M	0.27%	79

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Kingdon Capital Management's CLCD Position: Q1 2017 in Review

Kingdon Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 60,461 shares — an estimated $2.2M sold.

Kingdon Capital Management first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $5.91M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Kingdon Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Kingdon Capital Management sold 60,461 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2.2M.
Kingdon Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Kingdon Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $5.91M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Kingdon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.